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Abstract
The use of lavender oil (LO) – a commonly, used oil in aromatherapy, with well-defined vola-
tile components linalool and linalyl acetate – in non-traditional medicine is increasing glob-
ally. To understand and demonstrate the potential positive effects of LO on the body, we
have established an animal model in this current study, investigating the orally administered
LO effects genome wide in the rat small intestine, spleen, and liver. The rats were adminis-
tered LO at 5 mg/kg (usual therapeutic dose in humans) followed by the screening of differ-
entially expressed genes in the tissues, using a 4×44-K whole-genome rat chip (Agilent
microarray platform; Agilent Technologies, Palo Alto, CA, USA) in conjunction with a dye-
swap approach, a novelty of this study. Fourteen days after LO treatment and compared
with a control group (sham), a total of 156 and 154 up (≧ 1.5-fold)- and down (≦ 0.75-fold)-
regulated genes, 174 and 66 up- (≧ 1.5-fold)- and down (≦ 0.75-fold)-regulated genes, and
222 and 322 up- (≧ 1.5-fold)- and down (≦ 0.75-fold)-regulated genes showed differential
expression at the mRNA level in the small intestine, spleen and liver, respectively. The
reverse transcription-polymerase chain reaction (RT-PCR) validation of highly up- and
down-regulated genes confirmed the regulation of the Papd4, Lrp1b, Alb, Cyr61, Cyp2c,
and Cxcl1 genes by LO as examples in these tissues. Using bioinformatics, including Inge-
nuity Pathway Analysis (IPA), differentially expressed genes were functionally categorized
by their Gene Ontology (GO) and biological function and network analysis, revealing their
diverse functions and potential roles in LO-mediated effects in rat. Further IPA analysis in
particular unraveled the presence of novel genes, such as Papd4,Or8k5, Gprc5b, Taar5,
Trpc6, Pld2 andOnecut3 (up-regulated top molecules) and Tnf, Slc45a4, Slc25a23 and
Samt4 (down-regulated top molecules), to be influenced by LO treatment in the small
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intestine, spleen and liver, respectively. These results are the first such inventory of genes
that are affected by lavender essential oil (LO) in an animal model, forming the basis for fur-
ther in-depth bioinformatics and functional analyses and investigation.
Introduction
Aromatherapy has been defined or is referred to as “the use of concentrated essential oils that
are extracted from herbs, flowers and other plant parts to treat various diseases” (quoted from a
systematic first review by [1,2]). Historically claimed to be an ancient practice among early civ-
ilizations, it was only in 1936 that term aromatherapy was used by the French chemist Gatte-
fosse [3,4]. Although essential oils (which are usually distilled from medicinal plants or herbs)
have been traditionally used in Japan [5] and are generally known for providing vibrant health
and beauty, the official beginning of associations dealing with aromatherapy started in 1996
(Aroma Environment Association of Japan, http://www.aromakankyo.or.jp/english/aeaj.htmlJ;
Japanese Society of Aromatherapy (JSA), http://aroma-jsa.jp/). For further reading on medical
and clinical aromatherapy, readers are referred to [6] and [7].
Among the Japanese people, aromatherapy is widely used or applied and in numerous ways
[8]; the main application methods of essential oils include the inhalation of the volatile compo-
nents (e.g., menthol, limone, and linaol vapors) and the percutaneous absorption via the appli-
cation of diluted oil to the skin (e.g., sweet almond, Jojoba, grape seed oils). On the other hand,
the oral administration of essential oils (e.g., lavender oil; hereafter abbreviated as LO) is tradi-
tionally performed in some European countries [9] but is not popular in Japan. For example, in
France, Belgium, and Germany, LO is used as a form of herbal or natural medicine. Further-
more, a German pharmaceutical company produces an encapsulated form of LO preparation,
Silexan (W. Spitzner Arzmeimittelfabrik GmbH, Ettlingen, Germany). Recent animal and clin-
ical studies have generally shown beneficial effects of Silexan [10]. The reasons behind the non-
use of LO in Japan might be cultural or scientific; the authors believe that there is no concrete
evidence or studies for that matter regarding the safety aspects of ingesting essential oils (for
example LO).
Lavender oil, which is distilled from the species Lavandula angustifolia (Labiatae), is the
source for the commonly used oil in aromatherapy [11–13] and the subject of our current
investigation. The reason for the use of LO is first because LO is one of the most popular essen-
tial oils that are used in aromatherapy and whose use in non-traditional medicine is increasing
worldwide. Second, LO has the well-defined volatile components linalool and linalyl acetate in
almost equal amounts [14], the effect of which can be examined via the administration of LO
as oil. Although there some studies have investigated the effects of LO using the commercial
formulation Silexan [15], there is no study using a pure (100%) LO. The main novelty of this
study is however the use of an omics-based approach, namely transcriptomics by whole
genome DNAmicroarray [16] analysis of a rat model to which LO was orally administered LO.
To best of our knowledge, there is no such study employing a genome-wide approach.
To unravel the LO-influenced genes in the rat model, we first carried out a pilot study to
confirm the incorporation of two major LO components, linalool and linalyl acetate, in the
blood post-oral administration. The pilot study quantified linalool and linalyl acetate in the rat
plasma after oral administration of LO (S1 Fig). The venous blood from the heart and the por-
tal vein was collected and the presence or absence of these two components was determined
using a gas chromatography-mass spectrometry (GC-MS) technique. GC-MS analysis revealed
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the presence of linalool and linalyl acetate in the portal vein and this was quantified in a time-
dependent manner (S1 Fig). However, these two components could not be detected from the
heart (data not shown). As both linalool and linalyl acetate were found in the blood (portal
vein), LO was indeed incorporated into the body of the rat, and which provided confidence to
take the experiment to the next step toward investigating effects of orally administered LO in
the rat model. For the DNAmicroarray experiments, the rats were orally administered LO at 5
mg/kg (the usual therapeutic dose in humans) followed by the screening of differentially
expressed genes in the small intestine, spleen, and liver, using a 4×44-K whole genome rat chip
(Agilent) and the dye-swap approach [17–22]. The experimental strategy is illustrated in Fig 1.
It was hypothesized that LO administration at a low-dose would induce changes in the gene
expression profiles starting with the small intestine, where the oil is perceived and ingested,
and probably acting as a site for first pass metabolism, followed by LO (linalool and linalyl ace-
tate) transport through the blood to the liver (and spleen), where further metabolism takes
place [23].
As expected, our results indicate that LO influences the expression of numerous genes in
these tissues/organs. These results are i) presented as a resource for the scientific community as
a first such inventory of genes that are affected by LO in a rat model and ii) discussed in the
context of the use of LO for human health and therapeutic properties. Moreover, using bioin-
formatics approaches, these genes have been functionally categorized by their Gene Ontology
Fig 1. The experimental strategy to screen for genes that are influenced by lavender oil (LO). Rats (7 weeks old) were given lavender oil (LO) orally
once each day for 13 days, and on the 14th day, the small intestine, spleen and liver were dissected out and deep frozen in liquid nitrogen. DNAmicroarray
analysis was performed using a rat whole-genome DNAmicroarray chip (G4131F, Agilent), and the differentially expressed genes were identified in the LO-
treated tissues followed by bioinformatics analyses. For further details, see the Materials and Methods section.
doi:10.1371/journal.pone.0129951.g001
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(GO) and are presented and briefly discussed in line with available literature with an aim of
correlating some of the changed gene expressions with LO affects.
Materials and Methods
Animals and husbandry and ethics statement
Fischer (F334) rats were purchased from Japan SCL (Hamamatsu, Japan). Twelve male rats
(7 weeks old; ~142.8 to 167.5-g body weight) were housed at the Animal Institution in Showa
University. The rats were maintained in individual cages in isolated animal rooms with con-
trolled temperature and relative humidity with a 12-h light: 12-h dark schedule (lights were
turned on at 08:00 AM) and had access to laboratory chow and tap water ad libitum. All of the
animal experiments began after a period of acclimation of at least one week. All of the animal
care and experimental procedures were approved by the Institutional Animal Care and Use
Committee of Showa University (approval number M6031).
Administration of lavender oil, dissection and sampling of tissues for
molecular analysis
Lavender oil (LO; L. angustifolia, Biofloral, France) was administered to rats (n = 6 per each
group) directly into the stomach at a dose of 0 (10% ethanol; diluent: control group) or 5
mg/kg (in 10% ethanol: LO-administered group) once a day in the afternoon (11:25–13:50) for
13 days. Fourteen days after treatment, the rats were dissected under ether anesthesia. The
small intestine was sampled approximately 20 cm from the duodenum and washed by saline
(0.9% NaCl). The whole spleen was dissected out. Two blocks of 8 mm2 were sampled from the
whole liver. All of the dissected tissues were immediately immersed in liquid nitrogen (N2) and
stored at -80°C in a deep freezer.
Total RNA extraction, cDNA synthesis and reverse transcription-
polymerase chain reaction (RT-PCR)
The deep-frozen tissues were transferred to a pre-chilled (in liquid nitrogen) mortar and
ground with a pestle to a very fine powder with liquid nitrogen. Sample powders (small intes-
tine, spleen, and liver) were stored at -80°C until used for RNA extraction. The total RNA was
extracted from ~60-mg sample powder using the Qiagen RNeasy Mini Kit (Qiagen, Maryland,
MD, USA) [17–22]. The protocol is schematically described for reference in S2 Fig. To verify
the quality of this RNA, the yield and purity were determined spectrophotometrically with
NanoDrop (Thermo Scientific, Wilmington, DE, USA) and confirmed using formaldehyde-
agarose gel electrophoresis (data not shown). The cDNA synthesis and quality check by
RT-PCR were also previously described [17–22]. The synthesized cDNA quality was checked
using RT-PCR to confirm the expression of the house-keeping gene glyceraldehyde 3-phos-
phate dehydrogenase (Gapdh) as a positive control [24] (data not shown). The gene-specific
primer design is presented in Table 1.
Global gene expression analysis on a rat whole-genome DNA chip
The total RNA that was extracted from the small intestine, spleen, and liver tissues for each
control and LO-administered sample was pooled in each group prior to DNA microarray anal-
ysis (Rat whole genome 4×44-K:G4131F; Agilent Technologies, Palo Alto, CA, USA). The
reason for pooling the total RNA and not individual tissues (due to usually larger variability at
the tissue level than at the RNA level) for estimating the gene expression is two-fold. First,
pooling of the samples (total RNA) resulted in the use of lesser number of chips that was an
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economical/cost-effective option, in this study due to large number of tissues to be analyzed,
for the highly expensive microarray analysis [25]. Second, as there will be some level of biologi-
cal variability amongst the samples, we pooled the extracted total RNA to average out the
possible differences in expression of genes. A study on statistical implications of pooling RNA
samples also suggested that gene expression estimates are more precise in the pooled samples,
assuming mRNA abundances in individual samples averages out when pooled [26]. To note, a
recent paper has taken forward the concept of pooling mRNA samples in microarray experi-
ments further by suggesting the use of a smart pooling approach [27]. The total RNA (200 ng)
was labeled with either Cy3 or Cy5 dye using an Agilent Low-RNA-Input Fluorescent Linear
Amplification Kit (Agilent Technologies, Santa Clara, CA, USA). The fluorescently labeled tar-
gets of the control as well as the treated samples were hybridized to the same microarray slide
with 60-mer probes. A flip-labeling (dye-swap or reverse labeling with Cy3 and Cy5 dyes) pro-
cedure was followed to nullify the dye bias that was associated with the unequal incorporation
of the two Cy dyes into cDNA (Fig 2). Briefly, to select differentially expressed genes by the
dye-swap approach, we considered genes that were up-regulated in chip 1 (Cy3/Cy5 label for
control and LO-administered samples, respectively) but down-regulated in chip 2 (Cy3/Cy5
label for LO-administered and control samples, respectively) for small intestine tissue. Simi-
larly, the same selection criteria were applied for chips 3 and 4 (spleen tissue), for chips 5 and 6
(liver tissue pool 1) and for chips 7 and 8 (liver tissues pool 2). The use of a dye-swap approach
provides more-stringent selection conditions for changed gene expression profiling than the
use of a simple single/two-color approach [28]. The hybridization and wash processes were
performed according to the manufacturer’s instructions, and the hybridized microarrays were
scanned using an Agilent Microarray scanner G2505C. To detect significantly differentially
expressed genes between the control and treated samples, each slide image was processed using
Agilent Feature Extraction software (version 11.0.1.1). This program measures the Cy3 and
Cy5 signal intensities of whole probes. Dye bias tends to be signal-intensity-dependent; there-
fore, the software selected probes using a set-by-rank consistency filter for dye normalization.
Said normalization was performed by LOWESS (locally weighted linear regression), which cal-
culates the log ratio of dye-normalized Cy3- and Cy5 signals and the final error of the log ratio.
Statistical significance of the log ratio values obtained for individual microarray probes was cal-
culated using the “most conservative error model” default function of the Feature Extraction
software, by which both a propagated and a universal error model are evaluated, and the higher
(more conservative estimate of error) p-value of two error models was reported (Agilent Tech-
nologies [28]). In this analyses, the threshold of significant differentially expressed genes was
<0.01 (for the confidence that the feature was not differentially expressed). Additionally, the
erroneous data generated due to artifacts were eliminated before data analysis by the software.
Table 1. Gene-specific primers that were designed in-house and used for the RT-PCR analysis of gene expression.
Forward Primer Reverse Primer
Accession (Gene) Primer name Nucleotide sequence (5'-3') Primer name Nucleotide sequence (5'-3') Product size (bp) Gene Name
NM_017008 SR001 cctgtgacttcaacagcaactc SR002 ggcctctctcttgctctcagta 213 Gapdh
NM_001107843 SR045 aaaaatttggtcatggctcagt SR046 caccttcctcctgaataactgg 305 Lrp1b
NM_001008372 SR049 ccccatgtaatgttcctcctta SR050 tcttttcagggtagcagctctc 338 Papd4
NM_134326 SR041 caccaagtgttgtacccttcct SR042 tgggagtgtgcagatatcagag 250 Alb
AB015877 SR033 gtccttgtggacaaccagtgta SR034 cctttagtccctgaacttgtgg 341 CYR61
NM_031572 SR031 atggtttgttgcatgaagtgac SR032 aatggtggtcaggaacaaaaac 266 Cyp2c12
NM_030845 SR043 tccccaagtaatggagaaagaa SR044 acacgatcccagactctcatct 349 Cxcl1
doi:10.1371/journal.pone.0129951.t001
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To re-check some of the microarray data for semi-quantitative RT-PCR, an accepted meth-
odology to validate the microarray results in biological sciences, as detailed above, was per-
formed on selected genes using gene-specific primers (Table 1). Each gene expression analysis
was performed at least twice as independent PCR reactions and electrophoresis on a gel for
each cDNA (n = 6). The average mRNA abundance for each gene (control and LO) is
presented.
Functional categorization
Pathway and disease state-focused gene classification of the differentially expressed genes in
the small intestine, spleen, and liver were classified based on the available categories of more
than 100 biological pathways or specific disease states in the SABiosciences PCR array list (Qia-
gen; www.sabiosciences.com) for Rattus norvegicus.
Ingenuity Pathway Analysis (IPA)
The biological function and network analyses were performed using IPA (Ingenuity Systems,
www.ingenuity.com). Following our original submission, and during the revision, a new analy-
sis was performed using the IPA tool (Content version: 23814503, Release Date: 2015-03-22,
Qiagen). The dataset from the microarray (LO treatment in the small intestine, spleen, and
liver), which includes the differentially expressed (≧/≦ 1.5/0.75-fold compared with control)
genes and their corresponding fold change values, was uploaded as an Excel spread sheet into
Fig 2. The two-color and dye-swap approach was used for genome-wide analysis. Two DNA chips were
used for each sample condition, i.e., a dye-swap approach was used to label one set of RNAs by Cy 3 and
the other by Cy5 for each control and LO sample, respectively. A 4×44-K format slide containing 4 chips is
illustrated for the current study. For further details, see the Materials and Methods section.
doi:10.1371/journal.pone.0129951.g002
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the IPA tool. To create gene networks, the genes were overlaid onto a global molecular network
that was developed from information that was contained in the ingenuity knowledge base. The
functional analysis identified the biological functions that were most significant to the dataset
(p-value< 0.05) according to a right-tailed Fisher’s exact test.
Access to gene array data
The outputs of the microarray analysis that were used in this study are available under the
number series GSE 63640 (whole genome) at the NCBI Gene Expression Omnibus (GEO) pub-
lic functional genomics data repository (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE63640).
Results
Experimental strategy, dose and timing of lavender oil administration
and tissues sampling
The main compounds of LO are linalool (31.85%), linalyl acetate (31.00%), β-ocimene (8.85%),
and 1,8-cineole (4.4%) as described in the chemical datasheet by Biofloral. As neither linalool
nor linalyl acetate were present in the heart (venous blood) but were detected from the portal
vein (S1 Fig), we considered the first-pass effects in the liver after the oral administration of
lavender essential oil (LO). To note, a study in 1990 demonstrated the presence of LO fragrance
compounds in blood samples of rat [29]. The presence of these two components in the blood
has also previously been shown in human subject’s blood samples after transdermal application
of LO in a 1992 study [30] and following oral administration of LO preparation Silexan in 2010
and 2013 studies [31,32]. There are no other reports to our knowledge in animal models, and
which also raises the question of the metabolism of these two major LO components. Accord-
ing to the PubChem compound database, hydrolysis of linalyl acetate occurs in the gastric flu-
ids and the reaction products are linalool and acetic acid; therefore it has been mentioned that
linalool would enter the systemic circulation [33]; for linalool, it is rapidly absorbed and there-
after metabolized [34]. We cannot explain this further without experimental evidences, but our
results on the higher level of linalool may support this report. The path of LO is thus assumed
from the small intestine and/or spleen via the portal venous system to the liver. As illustrated
in Fig 1, the LO was administered orally to the rats (5 mg/kg once a day for 13 days), including
the sham (control group, 10% ethanol), and 14 days after treatment, the intestine, spleen, and
liver were dissected out to examine the differentially expressed genes.
The reason for selecting the time point and dose was based on a preliminary trial where
LO was administrated to male Fischer rats at a dose of 0, 5 mg/kg (clinical dose), or 500 mg/kg
(1/10 dose of the LD50). At one or six hours after the oral administration, we collected the
liver and investigated into the genome-wide gene expression profiles on a rat whole genome
4×44-K DNAmicroarray chip (Kubo et al., unpublished data). For the 5 mg/kg LO dose, only
11 & 12 up (>1.5-fold)–and down (<0.75-fold)–regulated genes were found at one hour after
administration, and 27 & 22 up (>1.5-fold)–and down (<0.75-fold)–regulated genes at six
hours after LO administration. For the 500 mg/kg LO dose, 44 & 17 up (>1.5-fold)–and down
(<0.75-fold)–regulated genes were found at one hour after administration, and 111 & 49 up
(>1.5-fold)–and down (<0.75-fold)–regulated genes at six hours after LO administration.
These low number of gene expression changes were insufficient to discuss about the influence
of the oral administration of LO. In traditional way of use, usually 10 to 20 days of continuous
daily administration of essential oils is used or recommended, followed by one-week interval
prior to the next round. Keeping this time of administration and the preliminary data on
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5 mg/kg over 500 mg/kg LO administration in mind, we focused on a two-week experiment
using the low-dose (5 mg/kg), as described in Materials and Methods section, for determining
the influence of LO on the body of rat.
Total RNA extraction and confirmation ofGapdh gene expression by
RT-PCR
To investigate global changes in gene expression in the small intestine, spleen, and liver, we
first optimized a protocol for total RNA extraction, especially for the small intestine, for the
first time in our research. The quantity and quality of the total RNA were confirmed, and this
RNA was then used to synthesize cDNA. Prior to DNA microarray analysis, we examined of
commonly used house-keeping gene Gapdh in the small intestine, spleen, and liver, allowing us
to subsequently use this gene as a positive control rather than by simply loading or using inter-
nal controls [24]. This simple test of gene expression showed that the mRNAs for Gapdh were
expressed almost uniformly across conditions; i.e., primarily to check its mRNA abundance in
all samples and not as a mathematical adjustment or denominator for gene expression calcula-
tions. Recently, we showed similar expression levels (probe signal intensity) for the Gapdh gene
with Cy3 and Cy5 labels in a microarray experiment on the ischemic brain [28]. Using the
same analysis approach, we found that the Cy3 and Cy5 label associated expression for all the
10 Gapdh (probes) is similar across all probes plotted on the microarray chip (S3 Fig). Results
showed a good correlation between the Cy3 and Cy5 labels expression points across the
1.5-fold change ratio. Following this preliminary analysis of sample quantity and quality based
on the total RNA check, we conducted a DNA microarray analysis with a dye-swap method
(Fig 2) using the small intestine, spleen, and liver samples; pooled samples (total RNA) were
used as detailed above in the Materials and Methods section. The reason for multiple checks as
mentioned above is important in any gene expression analysis experiment and is especially
true for a DNAmicroarray-based approach. The resulting data on gene expression changes
can be easily misinterpreted if any of the above steps are not followed precisely.
Global gene expression analysis by DNAmicroarray
DNAmicroarray analysis revealed 156 and 154 up (>1.5-fold)- and down (<0.75-fold)-regu-
lated genes in the small intestine, 174 and 66 up- and down-regulated genes in spleen, and 222
and 322 up- and down-regulated genes in liver (Fig 3). At a glance, up-regulated genes were
predominant in small intestine and spleen, whereas the liver showed more down-regulated
genes than up-regulated genes. The liver was also the organ with the largest numbers of gene
expression changes. These genes are listed in S1 Table (small intestine), S2 Table (spleen), and
S3 Table (liver). These results provide the first inventory of an essential oil (LO)-triggered gene
expression in an animal (rat) model.
Validatory RT-PCR analysis
To confirm alterations in the gene expression as observed by DNAmicroarray, we selected one
of each of the up- and down-regulated genes in the small intestine (Papd4, induced; Lrp1b, sup-
pressed), spleen (Alb, induced; Cyr61, suppressed), and liver (Cyp2c12, induced; Cxcl1, sup-
pressed); these genes and their specific primers are listed in Table 1. The DNAmicroarray data
can be re-confirmed by RT-PCR using appropriate primer (gene-specific) design and using
various cycles in order to measure the expression level under the most appropriate conditions
(not at plateau) (Fig 4). Not only did we visually confirm the amplified bands on a gel (1.8%
agar and Mupid-ex electrophoresis system, Advance, Tokyo, Japan), but also included a soft-
ware/image analysis tool post-visualization using a ChemiDoc XRS+ (Bio-Rad Laboratories,
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Inc., Hercules, CA, USA) to quantify the area/intensity of the bands. The up- and down-regula-
tion of the six genes were confirmed by RT-PCR, validating the obtained microarray experi-
mental data.
Functional categorization of differentially expressed genes by LO
treatment
The functionally categorized genes post-analysis using the SABiosciences PCR array list
(Qiagen) are presented graphically in Fig 5 (small intestine), Fig 6 (spleen) and Fig 7 (liver).
In Figs 5 and 6 and 7 the numbers on the y-axis represent the number of genes in each
category, which are indicated on the x-axis. The gene function and the genes description con-
tained within each functional category are shown for small intestine (up-regulated, S4 Table;
down-regulated, S5 Table), spleen (up-regulated, S6 Table; down-regulated, S7 Table), and
Fig 3. Differentially expressed genes in the small intestine, spleen, and liver. The histograms show the
up (red)- and down (blue)-regulated gene (≧/≦ 1.5/0.75-fold) numbers in each examined tissue.
doi:10.1371/journal.pone.0129951.g003
Fig 4. Validatory RT-PCR of selected differentially expressed up- and down-regulated genes in the small intestine, spleen, and liver. The graphs
show the up (red)- and down (blue)-regulated genes (gene-specific primers are given in Table 1) in each tissue under the control and LO treatment. LO,
lavender oil.
doi:10.1371/journal.pone.0129951.g004
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liver (up-regulated, S8 Table; down-regulated, S9 Table). Some interesting facts could be ascer-
tained using the known gene classifications. First, in the case of the small intestine, although
up-regulated genes were more abundant (even by two genes), the functions were mainly down-
regulated (Fig 5). In the case of the spleen, additional functions were correlated with additional
up-regulated genes, as seen in Fig 6. In the liver, more down-regulated genes numbers also cor-
related with more functions (Fig 7). These functions were characterized by the presence of
genes on both sides, up- and down-regulated. Interestingly and common to all the three tissues,
among the up-regulated genes, there were pockets of functions that were specific to the induced
genes only; these pockets are marked by boxed areas with broken lines (Figs 5 and 6 and 7),
indicating that the LO specifically influenced some known genes and functions as up-regula-
tion rather than down-regulation under the present analysis conditions of utilizing the well-
annotated genes and functional categories as referenced from Qiagen (see Materials and Meth-
ods section above). In the small intestine, the G protein-coupled receptors gene function was the
most highly up-regulated; in the spleen, themolecular toxicology pathway finder and G protein
coupled receptors were the top-two highly up-regulated gene functions; and in the liver, the cell
cycle was the highest up-regulated function. This regulation indicates diverse gene functions
being influenced by LO ingestion in these three different tissues. Therefore, the first objective
of identifying genes and their functions by DNAmicroarray in conjunction using an annotated
gene function list was achieved.
As a second step, for a wider bioinformatics analysis, we further performed a biological
function and network analysis using the IPA tool (as described in the Materials and Methods
section above). The numerous networks and pathways that were generated by this analysis
revealed that LO can affect the small intestine, spleen, and the liver in complex ways. To
explain the genes influenced by LO the top three networks (1, 2, and 3) have been presented
and discussed in relation to the LO effects in small intestine (Fig 8), spleen (Fig 9) and liver
(Fig 10). Each tissue/organ IPA analysis also provided a list of top molecules that are gene can-
didates for the potential mechanism/s underlying the LO effects in the rat model. These genes
are listed in sequence of high to low expression in Table 2. We further discuss these gene
expression patterns and their possible role/function in the context of LO use as an aroma thera-
peutic treatment.
Discussion
The main goal of the present study–the establishment of an animal model for investigating the
effects of orally administered LO–was fulfilled by using a rat model in conjunction with an
omics approach, namely DNAmicroarray (rat DNA microarray chip, 4×44-K) technology for
the downstream analysis of target tissues/organs. The hypothesis that a daily ingestion of LO
which corresponds to roughly the usual therapeutic dose in humans would cause differential
gene expression at the site of absorption and metabolism, namely, the small intestine and liver,
was proven by delineating the cellular responses to LO treatment. As the portal vein (portal
venous system) also connects to the spleen where the blood is then transported to the liver, we
also examined the spleen; moreover, it might also be a secondary target for LO. That these
genome-wide changes at the target organs in this study would relate to known genes previously
shown to be related to the effect of essential oils was evident from the analysis of up-regulated
Fig 5. Pathway- and disease states-focused gene classification of genes in the small intestine of LO-treated rats. The genes (up-regulated–A; down-
regulated–B) were classified based on the available categories of more than 100 biological pathways or specific disease states in the SABiosciences PCR
array list (QIAGEN; www.sabiosciences.com) for Rattus norvegicus. The numbers in the Y-axis represent the number of genes in each category as indicated
on the X-axis.
doi:10.1371/journal.pone.0129951.g005
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and down-regulated genes using both GO and biological functions analysis. In addition, many
novel LO (and linalool, linalyl acetate) effects were distinguished using the IPA bioinformatics
tool. We discuss below each of the six genes that were used for RT-PCR analysis and some of
the top molecules and networks that were obtained from the IPA analysis in the context of LO
action and probable effects.
Gene expression analysis validation by RT-PCR and IPA analysis of top
three networks 1, 2, and 3, and top molecules reveal the influence of LO
treatment in a rat model
Highly up-regulated genes by LO treatment. Small intestine: Papd4 (PAP-associated
domain containing 4) gene, also known as the poly(A) RNA polymerase GLD2, encodes a pro-
tein that is involved in the process of RNA polyadenylation (http://www.ncbi.nlm.nih.gov/
gene/361878). As recently reviewed, messenger RNA polyadenylation and deadenylation are
critical cellular processes for the rapid regulation of gene expression under diverse conditions
to which cells are exposed to [35]. Although we cannot explain the reason behind Papd4 up-
regulation by LO, one reason is obvious: the small intestinal cells were exposed to the oil-rich
environment and responded by the activation of the expression of this gene. Another reason
for the expression of this gene may be related to the microRNAs, their function in lipid homeo-
stasis and interestingly where the role of especially GLD2 in the 3’-end adenylation of miR-122
was found [36,37]. Nevertheless, the possibility of LO mediating the expression of a RNA poly-
merase involved in microRNA stability is intriguing. This gene was also identified as a top mol-
ecule by IPA analysis, indicating its specificity to certain cellular functions that are affected by
LO.
The second top-ranking molecule was a newly annotated gene Or8k5, which encodes for an
olfactory receptor, family 8, subfamily K, member 5 protein (human: http://www.ncbi.nlm.nih.
gov/gene/361878; rat ortholog: http://www.ncbi.nlm.nih.gov/gene?cmd=Retrieve&dopt = full_
report&list_uids=405253). This gene is reported here for the first time to be responsible to LO
treatment, and is interesting because this family of proteins as the name indicates are related to
the olfactory signaling pathway and signaling by G-protein-coupled receptors (GPCR), where
they function to recognize and transduce the odorant signal, in our case, LO. Although this
gene function in the small intestine is a first report and its role cannot be inferred without fur-
ther experimental evidence, its identification suggests that odorant receptors might also be
present in the digestive tract other than the nasal tract. Interestingly, the Or8k5 was part of the
top 3rd network in the small intestine further suggesting a certain role in its induction by LO
(Fig 8, bottom network).
In addition, we also identified theMmp19 (matrix metallopeptidase 19) gene, which func-
tions in calcium ion binding and metalloendopeptidase activity plays a crucial role in the peri-
cellular proteolysis of the extracellular matrix and cell surface molecules (http://www.ncbi.nlm.
nih.gov/gene/304608) as the third top-ranking molecule. Based on these known functions, the
up-regulation ofMmp19 is not unexpected, but not much is known about the physiological
role of this gene in the intestine or under essential oils. In this regard, a citrus extract contain-
ing flavanones was found to induce the expression of genes that are involved in tissue repair
Fig 6. Pathway- and disease states-focused gene classification of genes in the spleen of LO-treated
rats. The genes (up-regulated–A; down-regulated–B) were classified based on the available categories of
more than 100 biological pathways or specific disease states in the SABiosciences PCR array list (QIAGEN;
www.sabiosciences.com) for Rattus norvegicus. The numbers in the Y-axis represent the number of genes in
each category as indicated on the X-axis.
doi:10.1371/journal.pone.0129951.g006
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and inflammation in human colon fibroblasts, including theMmp12 gene [38]. A literature
survey for theMmp19 functions revealed two papers. In the first study, MMP19 protein was
demonstrated as essential for T cell development and T cell-mediated cutaneous immune
responses in mice [39]. In the second study, MMP19 protein was identified as a key regulator
of lung fibrosis in mice and humans, suggesting that the up-regulation of MMP19 by lung
injury may play a protective role in the development of fibrosis through the induction of pros-
taglandin-endoperoxide synthase 2 [40].
Another interesting gene candidate was the Gprc5b (GPR, family C, group 5, member B)
gene, whose function is not well known but, as the name implies, has a GPCR and protein
kinase activator activities (http://www.ncbi.nlm.nih.gov/gene/293546). This gene was also
identified as the eight top-ranking molecules. Previously, Ito and co-workers have reported on
the anatomical and histological mRNA expression profiles of orphan GPCRs in the gastrointes-
tinal tract, and among them interestingly, the Gprc5bmRNA expression was found preferen-
tially in the muscle-myenteric nerve layer, which is similar to the GPCRs expressed in central
and enteric nerve systems with regulatory roles throughout the gut-brain axis [41]. A recent
study reported that GPRC5B might be a control point in adipose signaling systems, linking
diet-induced obesity to type-2 diabetes [42]. Is it possible that this protein might function in
sensing LO and transmitting its effect via an inflammation-linked signaling pathway? Other
than Gprc5b, the 2nd top network in the small intestine revealed other GPR genes, Gpr158,
Gpr27, Gpr84, including the chemosensory receptor family member Taar5 (trace amine-associ-
ated receptor) further suggesting a certain role for the induced expression of these transmem-
brane receptors by LO in sensing the volatiles in its induction by LO (Fig 8, center network). In
particular, a recent report on the human TAAR5 revealed its specific activation by a highly vol-
atile aminic compound, trimethylamine, indicating its role as a molecular sensor for detecting
volatile amines [43]. In our study, identification of Taar5 gene expression and the generated
network (top network 2) revealing a cluster of GPRs and TAAR5 suggests the first step in sens-
ing LO might take place in the small intestine.
Spleen: In the spleen, we were not able to identify a major factor per se, but the three gener-
ated networks gave a hint into the molecular events being modulated by LO treatment. In the
top-ranking network 1, some of the key molecules were albumin (Alb), prolactin receptor
(Prlr), and estrogen receptor 2 beta (Esr2). The Alb (albumin, a plasma protein) gene is associ-
ated with numerous binding functions and processes and serves a stress biomarker (http://
www.ncbi.nlm.nih.gov/gene/24186). Does LO induce Alb gene expression as a stress effect of
the oil? Although the extrahepatic synthesis of plasma proteins in mammalian tissues has been
reported during stress/inflammation [44], it is not known what role the spleen plays in albumin
synthesis. Recently and again in the liver, it was shown that the immunomodulatory and anti-
oxidant function of albumin stabilizes the endothelium and improves survival in a rodent
model of chronic liver failure [45]. Thus, Alb expression might be a positive reaction to the per-
ception of LO in the intestine; however, it would be necessary to check the levels of serum/
plasma albumin in future studies. In network 1 (Fig 9, upper network), we found a link to both
Alb and AHSG (alpha-2-HS-glycoprotein), which is quite interesting because this protein has
been recently linked to obstructive sleep apnea patients with cardiovascular diseases as a
Fig 7. Pathway- and disease states-focused gene classification of genes in the liver of LO-treated
rats. The genes (up-regulated–A; down-regulated–B) were classified based on the available categories of
more than 100 biological pathways or specific disease states in the SABiosciences PCR array list (QIAGEN;
www.sabiosciences.com) for Rattus norvegicus. The numbers in the Y-axis represent the number of genes in
each category as indicated on the X-axis.
doi:10.1371/journal.pone.0129951.g007
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salivary biomarker [46]. It is tempting to link this finding to the use of LO in helping people
relax and sleep [47–49].
The Prlr gene (http://www.ncbi.nlm.nih.gov/gene/24684) was found to interact with the
Esr2 (http://www.ncbi.nlm.nih.gov/gene/25149) gene. Although the link to LO is not known,
prolactin, a pituitary hormone well known for its role in reproduction also influences the
immune system via binding to its receptor (PRLR) in the immune cells [50]. Looking at the top
network 1, some key genes that are well known to be involved downstream of the activation of
the prolactin receptor also grouped in the pathway, namely signal transducer and activator of
transcription (Stat5a/b) and protein kinase B (Akt); though these gene expressions were not at
the cut-off range in our DNA microarray analysis. Both the STAT and AKT pathways are also
important molecules/signaling points downstream of the cellular signals, including growth fac-
tors, cytokines, etc [51–53], suggesting that LO (linalool/linalyl acetate) might act as a potent
cellular signal. Another interesting gene that was identified as the ninth ranking molecule and
in network 1 as the central molecule was the Esr2 gene that binds estrogen and mediates tran-
scriptional activation (http://www.ncbi.nlm.nih.gov/gene/25149). The Esr2 gene was a surpris-
ing discovery, and subsequent studies have established that this ERbeta as it is also known
plays only a minor role in mediating estrogen action in uterus and other classical estrogen tar-
get tissues but has a more defined role in the ovary, cardiovascular system and brain, including
animal models of inflammation [54]. However, there is a demonstrated link between prolactin
and stimulation of ERalpha and ERbeta in rat corpus luteum and decidua of pregnancy [55].
Interestingly, mutation studies of the Stat5 response elements indicated that PRL regulation of
ER expression requires both intact Stat5 binding sites as well as functional Stat5 [55].
The Trpc6 (transient receptor potential cation channel, subfamily C, member 6) gene
(http://www.ncbi.nlm.nih.gov/gene/7225) encoding non-selective cation channels [56,57] was
also identified as a top molecule by IPA analysis (it was also a key molecule in network 6; data
not shown). Much is known about this gene in the kidney functions and its diseases [58], and
Trpc6 function has been identified in smooth muscle and axonal guidance. Although we know
very little about its role in the intestine, LO becomes a new extracellular stimuli triggering its
activation. Because the TRPC6 protein stimulates calcium influx [59,60] via phospholipase C-
mediated signals [58] and through angiotensin II activation involving reactive oxygen species
(ROS) in rat podocytes [61], it is possible that LO triggers some type of signaling cascade acti-
vating these channels directly or indirectly. Another recent study targeting the brain linked
oral LO use in patients suffering from subsyndromal anxiety and the involvement of voltage-
dependent calcium channels [62]. Regarding ROS, two key molecules were mapped in the
second-ranking network 2, namely, nitric oxide (NO) synthase 2 (Nos2, inducible; iNos) and
glutathione peroxidase family, the glutathione peroxidase 2 (Gpx2) genes. Nos2 is a cytokine-
inducible enzyme involved in NO production (http://www.ncbi.nlm.nih.gov/gene/24599) and
was identified as the 10th top-ranking molecule. Though there is no study available on LO caus-
ing the induction of Nos2 gene expression or activity, two reports exist in the literature showing
iNOS protein expression (and NO production) by oleuropein (bitter principle of olives) in
mouse macrophages [63] and in lung tissues of a murine model following Nigella sativa fixed
oil and dexamethasone treatment [64]. Gpx2 is involved in the negative regulation of the
inflammatory response to antigenic stimulus (http://www.ncbi.nlm.nih.gov/gene/29326) as the
second top-ranking molecule. Gpx2 gene knockout studies in mice showed that the mRNA
Fig 8. The top three networks (1, 2, and 3) for the small intestine by IPA analysis.Genes central to the pathway are placed aside each network in a box.
The genes (up-regulated–red; down-regulated–green) are networked based on the evidence in the IPA. For further details, see the Materials and Methods
section.
doi:10.1371/journal.pone.0129951.g008
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expression of Gpx2 and GPX-2 activity levels are induced by luminal microflora and demon-
strated a role for GPX as an anti-inflammatory molecule [65]. Moreover, this gene was also
identified as playing a role in alleviating the apoptotic response of MCF7 cells to oxidative
stress [66].
In the third top-ranking network, the N-methyl-D-aspartate (NMDA) receptor appears as a
key molecule. The beneficial effects of LO has been thought to be mediated in part through
interaction with the NMDA or GABAA receptors, voltage dependent sodium channels or cho-
linergic neurotransmission ([62,67], and references therein). This may be the first report show-
ing that NMDA receptor mRNA expression in the spleen can be increased by LO treatment.
Liver: The Cyp2c12 (cytochrome P450, family 2, subfamily c, member 12; coding for steroid
hydroxylases) gene is involved in oxidation-reduction processes (http://www.ncbi.nlm.nih.
gov/gene/25011). Although we cannot explain the reason for up-regulation of this liver enzyme
gene, it is interesting to note that there is a gender-related regulation of this gene expression in
rats [68], with modulation by growth hormone (GH) [69] and under cholestasis [70]. Many
questions remain than are answered by this gene induction by LO, primarily whether LO is
being simply metabolized by this enzyme or if there is more to the effects of LO in the context
of sexual dimorphism and GH effects. The Pld2 (phospholipase D2) gene encodes an enzyme
that catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline and is
involved therein in signal transduction, membrane trafficking and mitosis regulation (http://
www.ncbi.nlm.nih.gov/gene/25097). This gene was also identified as a top molecule by IPA
analysis. In general, the action of phospholipases, including PLD and PLC, produces lipid
mediators, including prostaglandins and metabolites of arachidonic acid, which play important
roles in hepatocyte proliferation. We also identified the one cut homeobox 3 (Onecut3) gene
encoding for the ONECUT class of transcription factors. The ONECUT1 (HNF-6) is the main
member which was shown to be involved in endoderm differentiation to various organs,
including the pancreas and liver, including working as part of a regulatory cascade between
two paralogous transcription factors, OC-1 and OC-3 [71,72]. Recently, HNF-6, OC-2 and
OC-3 (Onecut3) have been found to also control the development of Locus Coeruleus (the
main noradrenenergic nucleus in the vertebrate central nervous system), which regulates sev-
eral processes such as arousal, sleep, adaptive behaviors and stress [73]. We cannot explain the
presence of Onecut3 gene and its induction by LO treatment in the liver, at present.
Looking at networks 1 to 3, we could not find some key molecules or factors but individual
genes up-regulated / down-regulated in each network. We further discuss some of these highly
changed molecules. The network 1 contained a highly induced gene, Prol1 (proline rich, lacri-
mal 1). There is no literature on the Prol1 gene induction by essential oils, but the human
opiorphin, a recently identified endogenous pentapeptide encoded by Prol1, was shown to con-
tribute to cardiovascular modulation / blood pressure through the angiotensin II pathway [74].
In addition, calpain proteins, encoded by Capn8 (http://www.ncbi.nlm.nih.gov/gene/170808)
and Capn3 (http://www.ncbi.nlm.nih.gov/gene/29155) genes were prominently present in the
network 1. The calcium-dependent proteases have numerous functions including cell survival,
plasticity, and motility, though we do not anything about their function in liver following LO
treatment. In network 2, insulin receptor substrate 2 (Irs2) gene was a main molecule, and its
encoded protein plays a role in insulin-stimulated fetal liver growth (http://www.ncbi.nlm.nih.
gov/gene/29376). The IRS2, an essential insulin receptor adaptor protein was shown to be
Fig 9. The top three networks (1, 2, and 3) for the spleen by IPA analysis.Genes central to the pathway are placed aside each network in a box. The
genes (up-regulated–red; down-regulated–green) are networked based on the evidence in the IPA. For further details, see the Materials and Methods
section.
doi:10.1371/journal.pone.0129951.g009
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involved in the regulation of hepatic lipid metabolism by adiponectin via IRS-2 phosphoryla-
tion in OLETF rats [75], and most recently a critical role in hepatic insulin signaling via the
liver Hif-2α-Irs2 pathway that is modulated by Vegf inhibition [76]. In the network 3, fibro-
blast growth factor (FGF) was the dominant molecule, with Fgf1 (http://www.ncbi.nlm.nih.
gov/gene/25317), Fgf21 (http://www.ncbi.nlm.nih.gov/gene/170580), and Fgfr1 (http://www.
ncbi.nlm.nih.gov/gene/79114) genes being differentially expressed. In the liver, FGFR signaling
has been demonstrated to play a central role in repair after liver injury, i.e., it is crucial for liver
homeostasis and regeneration [77]. Most recently, a breakthrough has been made in the use of
FGF1 as a therapeutic agent for the treatment of insulin resistance and type-2 diabetes [78]. In
case of the Fgf21, a role for this factor in metabolic adaptations, not only in the ketotic sate but
also to face an unbalanced nutritional situation was suggested [79]. A recently published report
has provided novel insight into FGF21-induced cardiac effects in obesity and ischemia [80].
Down-regulated genes by LO treatment
Small intestine: Although there is no information on the Lrp1b (low-density lipoprotein recep-
tor-related protein 1B) gene (http://www.ncbi.nlm.nih.gov/gene/311926) in relation to the
intestines, a recent report indicated that LRP1B protein may function as a tumor suppressor
against renal cell cancer (RCC) and is possibly be involved in the regulation of cell motility and
actin cytoskeleton reorganization in RCC [81]. In addition, in network 1, the Tnf (tumor necro-
sis factor) gene, which acts as a cytokine and binds TNF receptors, playing a role in the induc-
tion of apoptosis and inflammatory response (http://www.ncbi.nlm.nih.gov/gene/?term=NM_
012675), was also identified as the central molecule. LO has proven benefits for inflammatory
bowel disease along with reduced levels of TNF-a, strongly supporting a potential for LO in
maintaining intestinal health by modulating the enteric microbial as recently demonstrated by
the use of Lavandula × intermedia cultivar Okanagan lavender (OLEO) in a mouse model of
acute colitis caused by Citrobacter rodentium [82]. We also identified two newly annotated
down-regulated top molecules. The first was the Iqck (IQ motif containing K) gene, where the
IQ motif serves to bind EF-hand proteins such as calmodulin (http://www.ncbi.nlm.nih.gov/
gene/100909537). Its function in rat remains unknown, but a human homolog was (http://
www.ncbi.nlm.nih.gov/gene/124152) was identified as a potential candidate gene for obsessive-
compulsive disorder in a genome-wide association study [83]. The other was Pappa2 (pappaly-
sin2; pregnancy-associated plasma protein-A2) gene which encodes for a member of the pap-
palysin family of metzincin metalloproteinases (http://www.ncbi.nlm.nih.gov/gene/364027).
PAPPA and PAPPA2 proteins are highly expressed in the human placenta, and known to
cleave the insulin-like growth factor (IGF)-binding proteins thereby increasing the availability
of growth factors [84]. PAPPA is well recognized as a marker for fetal genetic disorders and
adverse pregnancy outcomes, however, there physiological role of PAPPA2 remains unclear. A
recent study showed PAPPA2 up-regulation in severe pre-eclampsia and, functionally, this
may be mediated via increased placental hypoxia known to occur with this pregnancy disorder
[85]. How these proteins relate to the effect of LO remains to be uncovered, but a hint may lie
in a previous report where genetic down-regulation of PAPPA by a protease inhibitor reduced
ovarian cancer cell growth, invasion and metastatis via suppression of IGF-1-dependent Akt
and ERK1/2 activation [86].
Fig 10. The top three networks (1, 2, and 3) for the liver by IPA analysis.Genes central to the pathway are placed aside each network in a box. The
genes (up-regulated–red; down-regulated–green) are networked based on the evidence in the IPA. For further details, see the Materials and Methods
section.
doi:10.1371/journal.pone.0129951.g010
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Table 2. The topmolecules identified by IPA analysis after LO treatment.
Small intestine Spleen Liver
UP-REGULATED
PAPD4 PAP associated domain
containing 4
3.09 TRPC6 transient receptor potential
cation channel, subfamily
C, member 6
4.04 PLD2 phospholipase D2 4.09
OR8K5 olfactory receptor, family 8,
subfamily K, member 5
2.77 GPX2 glutathione peroxidase 2
(gastrointestinal)
3.86 GIPC2 GIPC PDZ domain
containing family,
member 2
2.95
MMP19 matrix metallopeptidase 19 2.59 WTIP Wilms tumor 1 interacting
protein
2.85 RPL39L ribosomal protein
L39-like
2.82
RAB28 RAB28, member RAS
oncogene family
2.57 SCAF11 SR-related CTD-
associated factor 11
2.81 OTUB2 OTU domain, ubiquitin
aldehyde binding 2
2.72
GADD45A growth arrest and DNA-
damage-inducible, alpha
2.51 IGSF8 immunoglobulin
superfamily, member 8
2.66 NDFIP2 Nedd4 family interacting
protein 2
2.66
ZCCHC3 zinc ﬁnger, CCHC domain
containing 3
2.49 ACSM2A acyl-CoA synthetase
medium-chain family
member 2A
2.60 NOS1AP nitric oxide synthase 1
(neuronal) adaptor
protein
2.66
PRKAR1B protein kinase, cAMP-
dependent, regulatory, type
I, beta
2.37 LOC686142
(includes
others)
similar to Ral guanine
nucleotide dissociation
stimulator (RalGEF)
(RalGDS)
2.55 ONECUT3 one cut homeobox 3 2.60
GPRC5B G protein-coupled receptor,
family C, group 5, member
B
2.32 ADIPOQ adiponectin, C1Q and
collagen domain
containing
2.48 LRRC16B leucine rich repeat
containing 16B
2.57
CYP46A1 cytochrome P450, family
46, subfamily A,
polypeptide 1
2.29 ESR2 estrogen receptor 2 (ER
beta)
2.36 IL12RB2 interleukin 12 receptor,
beta 2
2.52
FIBCD1 ﬁbrinogen C domain
containing 1
2.27 NOS2 nitric oxide synthase 2,
inducible
2.35 PRRG4 proline rich Gla (G-
carboxyglutamic acid) 4
(transmembrane)
2.51
DOWN-REGULATED
SLC45A4 solute carrier family 45,
member 4
-2.63 SLC25A23 solute carrier family 25
(mitochondrial carrier;
phosphate carrier),
member 23
-2.50 SAMT4 spermatogenesis
associated multipass
transmembrane protein 4
-4.17
ALOX12B arachidonate
12-lipoxygenase, 12R type
-2.63 GRIA1 glutamate receptor,
ionotropic, AMPA 1
-2.22 WSB1 WD repeat and SOCS
box containing 1
-3.57
DCLK2 doublecortin-like kinase 2 -2.38 CYR61 cysteine-rich, angiogenic
inducer, 61
-2.17 RHOBTB1 Rho-related BTB domain
containing 1
-3.23
FRMD6 FERM domain containing 6 -2.33 KLK11 kallikrein-related
peptidase 11
-2.08 SH3KBP1 SH3-domain kinase
binding protein 1
-3.13
IQCK IQ motif containing K -2.27 SCD2 stearoyl-Coenzyme A
desaturase 2
-2.04 ANKS4B SH3-domain kinase
binding protein 1
-3.13
PAPPA2 pappalysin 2 -2.22 GCG glucagon -2.04 AFF2 AF4/FMR2 family,
member 2
-2.94
ST13 suppression of
tumorigenicity 13 (colon
carcinoma) (Hsp70
interacting protein)
-2.17 WNT5B wingless-type MMTV
integration site family,
member 5B
-1.96 TM4SF4 transmembrane 4 L six
family member 4
-2.94
MTMR2 myotubularin related
protein 2
-2.17 DCLK1 doublecortin-like Kinase 1 -1.96 PAPLN papilin, proteoglycan-like
sulfated glycoprotein
-2.94
CTNNA3 catenin (cadherin-
associated protein), alpha 3
-2.13 TAAR5 trace amine associated
receptor 5
-1.89 ZNF280D zinc ﬁnger protein 280D -2.86
AGTR1B angiotensin II receptor, type
1b
-2.13 TMEM65 transmembrane protein 65 -1.85 SPTB spectrin, beta,
erythrocytic
-2.86
doi:10.1371/journal.pone.0129951.t002
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Spleen: The Cyr61 (cysteine-rich angiogenic inducer 61) gene encodes an extracellular bind-
ing protein (http://www.ncbi.nlm.nih.gov/gene/83476). Numerous experiments have revealed
that Cyr61 plays diverse roles in cellular proliferation, migration, differentiation, and angiogen-
esis, biological phenomena that are required for tumor growth and metastasis [87]. How LO
affects this gene expression and for what purpose remain to be identified. This gene was also
identified as the third top molecule by IPA analysis. The Slc25a23 (solute carrier family 25,
mitochondrial carrier/phosphate carrier, member 23) gene (http://www.ncbi.nlm.nih.gov/
gene/301113) was also identified as a top molecule by IPA analysis, though its function remains
to be clarified. One newly annotated down-regulated molecule was the Dclk1 (doublecortin-
like kinase 1; http://www.ncbi.nlm.nih.gov/gene/83825) gene, however its function also
remains to be clarified in context of LO treatment. Interestingly, DCLK1 is considered as a
putative pancreatic stem cell marker and is up-regulated in pancreatic cancer, colorectal cancer
and many other solid tumors [88], and might be a candidate for developing chemotherapeutic
agents.
Liver: The down-regulation of the Cxcl1 (chemokine (C-X- motif) ligand 1) gene (http://
www.ncbi.nlm.nih.gov/gene/81503) was observed with LO. A literature survey quickly revealed
that CXCL1 down-regulation inhibits tumor growth in colorectal liver metastasis [89]. The
Samt4 (spermatogenesis-associated multipass transmembrane protein 4) gene (http://www.
ncbi.nlm.nih.gov/gene/685774) was identified as a top molecule by IPA analysis, but we are at
loss to explain this gene expression. In addition, in network 1, the Ccnb1 (cyclin B1) gene
(http://www.ncbi.nlm.nih.gov/gene/25203) was also identified as the central molecule,
although here also we could not assign its role in the context of LO action. On the other hand,
four newly annotated down-regulated molecules were identified, namely the Aff2 (AF4/FMR2
family, member 2;http://www.ncbi.nlm.nih.gov/gene/293922), Papln (papilin, proteoglycan-
like sulfated glycoprotein; http://www.ncbi.nlm.nih.gov/gene/314297), Znf280d (zinc finger
protein 280D; http://www.ncbi.nlm.nih.gov/gene/315798), and Sptb (spectrin, beta, erythro-
cytic; http://www.ncbi.nlm.nih.gov/gene/314251) genes. Functions for these newly annotated
genes remain unclear. However, for the Aff2, its human ortholog, variously called FMR2 /
MRX2 / OX19 / FMR2P / FRAXE is associated with the fragile X E syndrome, a form of non-
syndromic X-linked mental retardation (http://www.ncbi.nlm.nih.gov/gene/2334).
Conclusions
We potentially identified some of the LO influenced genes that might be involved in mediating
the beneficial effects of this essential oil as an aromatherapy agent. The gene inventory for the
three tissues/organs, small intestine, spleen, and liver serves as a valuable resource for further
analysis and study. Based on the above identified differentially expressed genes by DNA micro-
array analysis and subsequent bioinformatic analyses, the essential oil of lavender (LO) can
cause a moderate activation of the small intestine, spleen, and liver inflammation- and lipid
homeostasis-related functions among other functions that are related to innate immunity and
the immune system. To note, LO may not be toxic (to rats) at the dosage used in this study as
on previous research evaluating the developmental toxicity of linalool in rats has indicated that
the maternal “no observed adverse effect level (NOAEL) was 500 mg/kg/day compared to the
developmental NOAEL at 100 mg/kg/day [90]. These gene inventories are the first step in
future experiments that will be required to reveal their precise function to confirm the recog-
nized effects of LO on humans. These experiments may involve checking, for example, the
effects of LO on stress or depression and sleep disorder models of animals to confirm the
involvement of some of the potential gene candidates that were screened in the present study.
Further functional analysis will be required to characterize the role of the genes that were
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identified in this study, and only then will it be possible to facilitate a deeper understanding on
how aroma oil benefits the human body. On the other, there are some limitations to our study.
The first order of research would be an exhaustive bioinformatics analysis and interplay of the
molecular factors at least among these three tissues/organs examined in the current study by
extensively utilizing all available functions in the IPA tool. The other immediate priority would
be to analyze the missing link in these transcriptomic data, namely the DNAmicroarray analy-
sis of the blood (raw transcriptomic data has just been submitted at the GEO website under
public access; accession number-GSE67499). The reasons are two-fold. First, blood is trans-
porting the LO (linalool and linalyl acetate) through the portal vein, and second, as at least lin-
alool was present at higher levels after LO treatment the blood should show transcriptomal
information/changes and which might also be a valuable resource in pharmagenomic studies
vis-à-vis LO. As also rightly stated by the anonymous referee, the appearance of linalool and
linalyl acetate (and possibly other LO components) in the portal venous sample but not in
venous (systemic) blood adds a level of complexity to interpret different gene expressions in
different tissues relative to the hepatic-portal versus systemic circulation. Understanding this
would be essential to predict or test responses in other tissues downstream from this hepatic-
portal system, especially in the context of the human use of LO for so many different effects.
One such target is the brain, as our research group is interested in the effects of molecules/pep-
tides and natural (biologically active) compounds on the brain, vis-à-vis neuroprotection.
Supporting Information
S1 Fig. Plasma linalool and linalyl acetate concentration in the portal vein after oral admin-
istration of lavender oil (LO). LO was administrated to male SD rats (n = 3) at a dose of
1.25 mg/kg. Blood samples (5 mL) were collected, in blood collection tubes containing 3.2%
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60 min after oral administration of LO. The plasma was centrifuged (3000 rpm, 10 min, 4°C)
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heating: 250°C; temperature program: 60°C (1 min) – 200°C (1 min)- 250°C (1 min); injected
volume: 1 mL; split-ratio: 50.0; carrier gas: helium. Discussion is in the text.
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S3 Fig. Expression level of the Gapdh gene, by expressed level of probe signal intensity in
Cy3 and Cy5 labels under DNAmicroarray experiment in the rat small intestine (A), spleen
(B), and liver (C). Ten probes for the Gapdh gene are plotted for both labels, Cy3 and Cy5.
DNAmicroarray was performed as described in Materials and Methods section.
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S1 Table. Lavender oil small intestine up- and down-regulated genes.
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S2 Table. Lavender oil spleen up- and down-regulated genes.
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S6 Table. Function of rat spleen genes up-regulated by LO.
(XLSX)
S7 Table. Function of rat spleen genes down-regulated by LO.
(XLSX)
S8 Table. Function of rat liver genes up-regulated by LO.
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